Viewray (NASDAQ:VRAY) is scheduled to issue its quarterly earnings data before the market opens on Friday, August 3rd. Analysts expect the company to announce earnings of ($0.21) per share for the quarter.
Viewray (NASDAQ:VRAY) last posted its quarterly earnings data on Thursday, May 10th. The company reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.20) by $0.09. The company had revenue of $26.19 million for the quarter, compared to analysts’ expectations of $15.50 million. Viewray had a negative net margin of 83.09% and a negative return on equity of 1,375.57%. Viewray’s revenue for the quarter was up 2029.3% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.54) earnings per share. On average, analysts expect Viewray to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Get Viewray alerts:Shares of Viewray traded up $0.04, hitting $11.96, during trading on Thursday, MarketBeat Ratings reports. The company had a trading volume of 41,761 shares, compared to its average volume of 1,759,789. The company has a current ratio of 3.79, a quick ratio of 3.04 and a debt-to-equity ratio of 0.77. The stock has a market cap of $855.19 million, a price-to-earnings ratio of -11.52 and a beta of 1.21. Viewray has a 52 week low of $4.83 and a 52 week high of $13.21.
VRAY has been the topic of several research analyst reports. ValuEngine upgraded shares of Viewray from a “hold” rating to a “buy” rating in a research report on Wednesday, July 4th. Jefferies Financial Group initiated coverage on shares of Viewray in a research report on Tuesday, July 3rd. They issued a “buy” rating and a $12.00 price objective on the stock. Mizuho restated a “buy” rating and issued a $12.00 price objective on shares of Viewray in a research report on Thursday, April 19th. Cantor Fitzgerald restated a “buy” rating and issued a $13.00 price objective on shares of Viewray in a research report on Friday, May 11th. Finally, BidaskClub upgraded shares of Viewray from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $12.10.
In other Viewray news, insider Fmr Llc sold 295,850 shares of the company’s stock in a transaction that occurred on Thursday, July 26th. The stock was sold at an average price of $12.08, for a total value of $3,573,868.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 43.93% of the stock is owned by corporate insiders.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Featured Story: Diversification
No comments:
Post a Comment